For individuals battling Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a debilitating condition, the arrival of this treatment and Tafamidis meglumine represents a genuine breakthrough . These groundbreaking therapies preserve the transthyretin protein, preventing its destructive build-up and lessening the burden of the condition . People are … Read More